AstraZeneca will buy AbelZeta Pharma’s 50% share of development and commercialization rights in China for a CAR-T therapy for ...

If developers want to remain relevant, they must act now and engage with software architecture, says Golo Roden.

In today's fast-paced world, taking care of our health is more important than ever. With countless wellness products, ...